| 1.57 Data as of May 20 |  -0.03 / -1.88%Today’s Change | 1.11 Today|||52-Week Range 3.30 | +18.05% Year-to-Date |
| Previous close | 1.60 |
| Today’s open | 1.63 |
| Day’s range | 1.57 - 1.64 |
| Volume | 301,208 |
| Average volume (3 months) | 1,194,083 |
| Market cap | $161.3M |
| Dividend yield | -- |
| Earnings growth (last year) | +69.90% |
| Earnings growth (this year) | +17.78% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +17.96% |
| P/E ratio | NM |
| Price/Sales | 2.42 |
| Price/Book | 11.14 |
| Today’s change | Today’s % change | |
|---|---|---|
| APDNApplied DNA Sciences... | -0.02 | -6.81% |
| AVEOAveo Pharmaceuticals... | -0.12 | -3.99% |
| OGXIOncoGenex Pharmaceut... | -0.07 | -0.67% |
| OMEROmeros Corp | +0.20 | +3.89% |
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $44.3M |
| Annual profit (last year) | -$47.4M |
| Net profit margin | -106.90% |
Sector Health Technology |
Industry Medical Specialties |
Chairman Cam L. Garner, MBA |
President & Director Stephen J. Farr, PhD |
Corporate headquarters San Diego, California |
.
